Boston Scientific Q1 2026 net sales $5.20B (+11.6% reported), adj EPS $0.80 (guidance $0.78-$0.80)

BOSTON SCIENTIFIC CORP

2026-Q1 EPS reported $0.90 revenue$5,203,000,000

GAAP EPS $0.90 vs $0.45 YoY; adjusted EPS $0.80 vs $0.75 YoY, at top of guidance.
Cardiovascular segment net sales $3.50B (+13.5% reported); MedSurg $1.70B (+7.8% reported).
FY2026 guidance: organic growth 6.5-8.0%; adj EPS $3.34-$3.41. Q2: organic growth 5.0-7.0%; adj EPS $0.82-$0.84.
WATCHMAN FLX trial (CHAMPION-AF) met all endpoints; FARAPULSE PFA showed superior long-term AF outcomes.
Acquired Valencia Technologies (eCoin system for urge incontinence); elected Cathy Smith and Christophe Weber to board.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

BOSTON SCIENTIFIC CORP reported first quarter ended March 31, 2026 results: revenue $5.203 billion, net income $1.341 billion or $0.90 per share (EPS), EPS $0.80.

Period: first quarter ended March 31, 2026
Revenue: $5.203 billion
Net income: $1.341 billion or $0.90 per share (EPS)
EPS: $0.80
Result: reported results

Exact text from the filing

(EX-99.1) --- Boston Scientific announces results for first quarter 2026 Marlborough, Mass. (April 22, 2026) -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.203 billion during the first quarter of 2026, growing 11.6 percent on a reported basis and 9.4 percent on an operational 1 and organic 2 basis, all compared to the prior year period. The

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

BOSTON SCIENTIFIC CORP filing history →

Source: SEC EDGAR

accession 0000885725-26-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.